Clinical Focus: Current Approaches to the Treatment of HR-Positive, HER2-Negative Metastatic Breast Cancer
  • Program Overview
    Clinical Focus: Current Approaches to the Treatment of HR-Positive, HER2-Negative Metastatic Breast Cancer
    In this review of HR-positive, HER2-negative metastatic breast cancer, Denise Yardley, MD, discusses and presents interactive case examples of the role of hormonal therapy in this disease and the prospects for further improvement of outcomes through the incorporation of novel agents.

Latest Content

2 of 2 Shown
2 of 2 Shown
Show 0 More
Loading...